Dr. Adewale Babatunde Ajumobi, MD

Dr. Ajumobi practices at Mirage Endoscopy Center in Rancho Mirage, California.

Dr. Ajumobi's NPI, 1871777698, was assigned on December 28, 2007. Dr. Ajumobi graduated from University of Ilorin Faculty of Health Sciences in 2000. Dr. Ajumobi holds California license A101199.

Dr. Ajumobi's primary practice is Mirage Endoscopy Center, at 39935 Vista Del Sol Road, Suite #101, Rancho Mirage, CA 92270. The practice phone is (760) 837-9210.

Dr. Ajumobi's primary practice is Mirage Endoscopy Center in Rancho Mirage, California. Dr. Ajumobi is also affiliated with Eisenhower Health. The medical group on file is Eisenhower Health. Dmand AI also links Dr. Ajumobi to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ajumobi practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Ajumobi's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Ajumobi is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Ajumobi's licenses on file in 2 states: California and Texas.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver and gastroenteritis among the conditions Dr. Ajumobi treats.

CMS data shows 1,221 Medicare services from Dr. Ajumobi across 15 procedure codes in 2024, for 720 Medicare patients. Medicare paid $128,051 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 720 Medicare patients who saw Dr. Ajumobi in 2024. The largest group is 65 to 74, with 353 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ajumobi's median patient age at 70, with 44% women.

In 2024, Dr. Ajumobi wrote 524 Medicare Part D claims for 311 patients. 76% of them were for generic drugs. CMS names the drug for 429 of them, across 10 drugs with 11 or more claims each, at $398,060 in total drug cost. In 2023, CMS named 306 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Ajumobi for performance year 2024, reported as part of a group. Dr. Ajumobi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ajumobi as offering telehealth. CMS counts 202 procedures of colonoscopy by Dr. Ajumobi, more than 94% of the clinicians it reports for that procedure.

Dmand AI links 14 papers to Dr. Ajumobi, published from 2009 to 2024. 2024 was the busiest year, with 4. The most frequent topics are Biopsy and United States Department of Veterans Affairs. Dr. Ajumobi has published most often in Cureus. Dr. Ajumobi's most frequent co-authors are Ammar Qureshi, MD, Roham Salman Roghani, MD and Jorge Corona, MD.

CMS Open Payments shows 61 general payments to Dr. Ajumobi from 17 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 63% of the total. Exact Sciences Corporation paid the most, $1,800.

Dmand AI lists 4 awards for Dr. Ajumobi, most recently Distinguished Teacher & Mentor of the Year in 2024.

Dr. Ajumobi graduated from University of Ilorin Faculty of Health Sciences in 2000. Dr. Ajumobi is a member of ACG, ACP, AGA and ASGE.

Dr. Ajumobi is in network with 15 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.